Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Novus Biologicals™ EVI5 Recombinant Protein Antigen
Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
Supplier: Novus Biologicals™ NBP258616PEP
Description
A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human EVI5. Source: E.coli Amino Acid Sequence: QPPFDGIHIVNHLIGDDESFHSSDEDFIDNSLQETGVGFPLHGKSGSMSLDPAVADGSESETEDSVLETRESNQVVQKERPPRRRESYSTTV The EVI5 Recombinant Protein Antigen is derived from E. coli. The EVI5 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.Specifications
7813 | |
EVI5 Recombinant Protein Antigen | |
PBS and 1M Urea, pH 7.4. | |
dJ846D11.1 (ecotropic viral integration site 5), ecotropic viral integration site 5, ecotropic viral integration site 5 protein homolog, EVI-5, NB4SNeuroblastoma stage 4S gene protein | |
Unlabeled | |
100μL | |
E.coli |
>80% by SDS-PAGE and Coomassie blue staining | |
Store at −20°C. Avoid freeze-thaw cycles. | |
Blocking/Neutralizing, Control | |
EVI5 | |
Recombinant Protein Antigen | |
RUO | |
This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-51877. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
For Research Use Only.
Spot an opportunity for improvement?
Provide Content Correction